Search our
Current Studies
DELIVER Double-blind, Randomized, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
Location(s): St. Augustine
Condition: Heart Failure
Protocol I8F-MC-GPHR(a) A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide versus Placebo in Patients with Nonalcoholic Steatohepatitis (NASH)
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Nonalcoholic Steatohepatitis
The NODE-303 Study: Multi-Centre, Multi-National,Open Label, …
Location(s): St. Augustine
Condition:
SELECT – Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity
Location(s): Jacksonville (Headquarters)
Condition: Heart Disease
A Phase 2b, Multicentre, Randomised, Double-blind, Placebo-controlled Study of Verinurad and Allopurinol in Patients With Chronic KIdney Disease and Hyperuricaemia
Location(s): Jacksonville- LaVilla (Downtown)
Condition: Kidney Disease
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown), Macon, St. Augustine
Condition: Cholesterol, Heart Disease
A Research Study to Look at How Semaglutide Compared to Placebo Affects Diabetic Eye Disease in People With Type 2 Diabetes (FOCUS)
Location(s): Jacksonville (Headquarters)
Condition: Diabetes
A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY Disease
Location(s): Jacksonville (Headquarters), Jacksonville- LaVilla (Downtown)
Condition: Kidney Disease